RAREBASE
RAREBASE
Social Links:
Founded:
2020-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.rarebase.org
Status:
Active
Technology used in webpage:
Domain Not Resolving Google Google Cloud Google Cloud Global Multi-Region Next.js Amazon California Region Symantec Secure Site Caddy Netlify Embedly
Similar Organizations
Chaperone Therapeutics
Chaperone Therapeutics is developing frontline therapies to address diseases of protein misfolding
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Minutia
Biotech, Therapeutics
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.rarebase.org Semrush global rank: 5.68 M Semrush visits lastest month: 1.48 K
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Rarebase"
Rarebase launches a neuroscience drug discovery …
PALO ALTO, Calif., Sept. 14, 2021 /PRNewswire/ -- Rarebase, a public benefit biotechnology company, launched a tech-enabled drug discovery platform called Function. Function's 15 patient...See details»
Rarebase launches a neuroscience drug discovery …
Sep 14, 2021 · Rarebase, a public benefit biotechnology company, launched a tech-enabled drug discovery platform called Function. Function’s 15 patient organization collaborators represent genes that cause epilepsy, autism, …See details»
Rarebase - Crunchbase Company Profile & Funding
Oct 4, 2020 · View contacts for Rarebase to access new leads and connect with decision-makers. Where is Rarebase's headquarters? Rarebase is located in Palo Alto, California, United States. Who are Rarebase's competitors? Alternatives …See details»
Rarebase Launches a Neuroscience Drug Discovery …
Rarebase, a public benefit biotechnology company, launched its tech-enabled drug discovery platform called Function. Function combines two unique data sets: large scale drug screens and genetic screens performed in neurons.See details»
Rarebase - Crunchbase Company Profile & Funding
Rarebase is a biotech and research and development firm. It offers to construct a modality-agnostic research roadmap to bring medicines to the clinic as well as a liberated collection of tools and resources to speed up therapeutic discovery, …See details»
Rarebase is on the hunt for therapeutic opportunities
Oct 31, 2022 · The big-data revolution in biomedical research has enabled Rarebase to address the gap in rare disease drug discovery in a novel way: by studying thousands of rare genetic diseases within a single research platform, …See details»
Rarebase launches a neuroscience drug discovery platform …
PALO ALTO, Calif., Sept. 14, 2021 /PRNewswire/ -- Rarebase, a public benefit biotechnology company, launched a tech-enabled drug discovery platfor...See details»
Rarebase Launches Collaborative Platform to Find New Therapies
Dec 30, 2021 · Rarebase, a public benefit biotechnology company, has launched the Function therapeutic discovery platform specifically for rare neurological diseases, including Batten …See details»
Rarebase Is on the Hunt for Therapeutic Opportunities - Yahoo …
Nov 7, 2022 · Rarebase, also located in the San Francisco Bay Area, was founded to develop a more scalable approach to drug discovery for the medically underserved rare disease …See details»
Rarebase launches a neuroscience drug discovery …
Sep 15, 2021 · PALO ALTO, Calif., Sept. 14, 2021 /PRNewswire/ -- Rarebase, a public benefit biotechnology company, launched a tech-enabled drug discovery platform called Function. Function's 15 patient organization collaborators …See details»
Rarebase Is on the Hunt for Therapeutic Opportunities
Nov 8, 2022 · The big-data revolution in biomedical research has enabled Rarebase to address the gap in rare disease drug discovery in a novel way: by studying thousands of rare genetic diseases within a single research platform, …See details»
Rarebase launches a neuroscience drug discovery platform
PALO ALTO, Calif., Sept. 14, 2021 /PRNewswire/ -- Rarebase, a public benefit biotechnology company, launched a tech-enabled drug discovery platform called Function. Function's 15 …See details»
Rarebase - VentureRadar
Rarebase is a public benefit corporation pioneering a new approach to biotech. We currently partner with over 15 patient organizations and families on translational therapeutic discovery …See details»
HNF collaborates with Rarebase on a Drug Discovery Platform to …
Oct 12, 2021 · Rarebase will screen a compound library of thousands of FDA-approved drugs and novel drugs, targeting ten subtypes of Charcot-Marie-Tooth (CMT).See details»
Transcripta Bio
Rarebase scientists partner with patient groups to use the genetic root cause of their rare diseases as a target to advance small molecule drug discovery.See details»
Founder Spotlight #17: Onno Faber @ Rarebase | by BIOS - Medium
Apr 27, 2021 · Onno Faber is Co-Founder & CEO @ Rarebase — identifying & developing infrastructure across rare disorders to accelerate therapeutic development. After spending a …See details»
How a Unique Biotech Company Partners With Charities to Find …
Nov 5, 2021 · In 2020, when then 39-year-old serial entrepreneur Onno Faber and his business partner Omid Karkouti founded Rarebase—a biotechnology company that raises money to find …See details»
Rarebase Announces Promotion of Chris Moxham to President
Jul 13, 2023 · Rarebase is a true platform drug development biotech that is revolutionizing the process of discovering and developing medicines at unprecedented speed, scale, and capital …See details»
Rarebase Names Chris Moxham as Chief Executive Officer
Oct 4, 2023 · Rarebase is a true platform drug development biotech that is revolutionizing the process of discovering and developing medicines at unprecedented speed, scale, and capital …See details»
Homepage – Rare
Rare is an international conservation and development organization using behavioral insights to inspire change so people and nature thrive.See details»